What does Medicenna Therapeutics Corp. do?

Medicenna Therapeutics Corp. is a public company in the Pharmaceutical Preparations industry, incorporated in Z4. It is registered with the SEC under CIK 0001807983 and trades on OTC under the ticker MDNAF.

How many SEC filings has Medicenna Therapeutics Corp. made?

Medicenna Therapeutics Corp. has filed 177 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Medicenna Therapeutics Corp.

MDNAF OTC CIK: 0001807983 Pharmaceutical Preparations Inc. in Z4

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 177 filings →

Form	Description	Date
15-12G	FORM 15	May 14, 2024
D	—	May 14, 2024
EFFECT	—	May 13, 2024
6-K	FORM 6-K	May 13, 2024
SC 13G	SC 13G	May 10, 2024
POS AM	POS AM	May 10, 2024
6-K	FORM 6-K	Apr 30, 2024
6-K	FORM 6-K	Apr 26, 2024
6-K	FORM 6-K	Apr 25, 2024
AW	FORM AW	Apr 22, 2024

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Medicenna Therapeutics Corp.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001807983
Ticker: MDNAF
Exchange: OTC
Incorporated: Z4
First Filing: 2020
Total Filings: 177

Pharmaceutical Preparations rankings →